Company Precision Biosensor, Inc.

Equities

A335810

KR7335810008

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

End-of-day quote Korea S.E. Other stock markets 03:30:00 24/05/2024 am IST			5-day change	1st Jan Change
4,250 ^KRW	+1.19%		-1.85%	-10.90%

25/03	Qlife Signs Letter of Intent with Precision Biosensor	CI
08/02	Precision Biosensor, Inc. announced that it has received KRW 3 billion in funding from Shinhan Investment & Securities Co., Ltd., Korea Investment & Securities Co., Ltd.	CI

PrecisionBiosensor Inc is a Korea-based company mainly engaged in the development, manufacture and sale of in vitro diagnostic reagents. The Company's main products include testers and cartridges. The testers are portable immunoassay diagnostic devices for on-site diagnosis that uses colorimetric and time-resolved fluorescence to check acute heart disease, metabolism, and inflammatory diseases. The cartridges are used in gold absorption and time-resolved fluorescence analysis diagnostic equipment, and can check acute heart disease, metabolism, and inflammatory diseases. The Company sells its products in domestic and overseas markets such as Europe, China, the Middle East, and Southeast Asia.

Number of employees: 102

KRW in Million	2022	Weight	2023	Weight	Delta
Immunodiagnostic Testers and Diagnostic Reagents Merchandise 98.4 %	1,478	7.2 %	20,064	98.4 %	+1,257.41%
Immunodiagnostic Testers and Diagnostic Reagents Manufactured Product 1.6 %	18,962	92.7 %	317	1.6 %	-98.33%
Service 0.0 %	18	0.1 %	10	0.0 %	-45.89%

KRW in Million	2022	Weight	2023	Weight	Delta
Europe 43.6 %	6,437	31.5 %	8,887	43.6 %	+38.05%
South Korea 29.3 %	5,764	28.2 %	5,979	29.3 %	+3.73%
Others 11.3 %	3,127	15.3 %	2,308	11.3 %	-26.21%
United States 10.4 %	3,365	16.4 %	2,131	10.4 %	-36.68%
China 5.3 %	1,765	8.6 %	1,087	5.3 %	-38.40%

Managers	Title	Age	Since
Han-Sin Kim CEO	Chief Executive Officer	56	01/18/01
Seung-Hoon Lee DFI	Director of Finance/CFO	51	01/19/01
Jong-Myeon Park CTO	Chief Tech/Sci/R&D Officer	51	01/18/01
Seung-Wan Son SAM	Sales & Marketing	55	01/22/01
Ho-Seok Lee AUD	Comptroller/Controller/Auditor	56	-

Members of the board	Title	Age	Since
Hak-Hyun Nam BRD	Director/Board Member	64	-
Jung-Wook Seo BRD	Director/Board Member	62	-
Han-Sin Kim CEO	Chief Executive Officer	56	01/18/01
Seung-Hoon Lee DFI	Director of Finance/CFO	51	01/19/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	11,614,526	6,882,975 ( 59.26 %)	0	59.26 %

Name	Equities	%	Valuation
I-SENS, INC. 28.20 %	3,275,630	28.20 %	10 M ₩
Korea Investment Partners Co., Ltd. 5.414 %	628,788	5.414 %	2 M ₩
Han-Sin Kim 3.182 %	369,614	3.182 %	1 M ₩
Dayli Partners Co. Ltd. 2.115 %	245,614	2.115 %	727 725 ₩
Hee-joon Kim 1.042 %	121,000	1.042 %	358 508 ₩
Hak-Hyun Nam 0.8610 %	100,000	0.8610 %	296 288 ₩
Seung-Hoon Lee 0.8179 %	95,000	0.8179 %	281 474 ₩
Ju-young Choi 0.8042 %	93,400	0.8042 %	276 733 ₩
Jong-Myeon Park 0.5805 %	67,417	0.5805 %	199 748 ₩
Geun-Sig Cha 0.5519 %	64,102	0.5519 %	189 927 ₩

Precision Biosensor, Inc.

306 Techno 2-ro Yuseong-gu

34036, Daejeon

http://www.precision-bio.com

address Precision Biosensor, Inc.(A335810)

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
PRECISION BIOSENSOR, INC.	-10.90%	3.57Cr
BIOMÉRIEUX	-4.92%	1.21TCr
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-5.82%	807.09Cr
DIASORIN S.P.A.	+5.43%	567.16Cr
LANTHEUS HOLDINGS, INC.	+26.16%	547.57Cr
AUTOBIO DIAGNOSTICS CO., LTD.	-9.58%	411.78Cr
10X GENOMICS, INC.	-59.63%	274.73Cr
ANDON HEALTH CO., LTD.	+8.44%	261.68Cr
VITROLIFE AB	-3.70%	232.76Cr
MYRIAD GENETICS, INC.	+21.00%	210.61Cr

Diagnostic & Testing Substances